compounded semaglutide injection FDA Warns on Certain Forms of Semaglutide | GoodGirlRx

Originally used for managing type 2 diabetes, Semaglutide GLP-1 is a glucagon-like peptide-1 (GLP-1) receptor agonist

"Patients finally have an obesity treatment available to them that actually works -- but because of ongoing challenges with supply -- they have to literally hunt down their medication, sometimes calling every pharmacy in their city just to come up empty," he wrote

An estimated 3.8 million beneficiaries could be eligible for the program based on a new KFF analysis of 2023 Part D enrollment data released today

As of 28 October 2024, the UK Government's med watch database (MHRA) received over 7,000 reports of gastrointestinal side effects linked to GLP-1RAs, with some resulting in hospitalization